Wei Jingwei, Brophy Brigid, Cole Sally-Ann, Moormann Jannis, Boch Jens, Laible Gӧtz
Animal Biotechnology, Ruakura Research Centre, AgResearch Ltd, Hamilton, New Zealand.
Institute of Plant Genetics, Leibniz Universität Hannover, Hannover, Germany.
Front Genet. 2022 Jul 11;13:925913. doi: 10.3389/fgene.2022.925913. eCollection 2022.
Genome editing provides opportunities to improve current cattle breeding strategies through targeted introduction of natural sequence variants, accelerating genetic gain. This can be achieved by harnessing homology-directed repair mechanisms following editor-induced cleavage of the genome in the presence of a repair template. Introducing the genome editors into zygotes and editing in embryos has the advantage of uncompromised development into live animals and alignment with contemporary embryo-based improvement practices. In our study, we investigated the potential to introduce sequence variants, known from the pre-melanosomal protein 17 () and prolactin receptor () genes, and produce non-mosaic, edited embryos, completely converted into the precision genotype. Injection of gRNA/Cas9 editors into bovine zygotes to introduce a 3 bp deletion variant into the gene produced up to 11% fully converted embryos. The conversion rate was increased to up to 48% with the use of TALEN but only when delivered by plasmid. Testing three gRNA/Cas9 editors in the context of several known sequence variants, different repair template designs and delivery as DNA, RNA or ribonucleoprotein achieved full conversion rates up to 8%. Furthermore, we developed a biopsy-based screening strategy for non-mosaic embryos which has the potential for exclusively producing non-mosaic animals with intended precision edits.
基因组编辑为通过靶向引入天然序列变异来改进当前的牛育种策略提供了机会,从而加速遗传进展。这可以通过在存在修复模板的情况下利用编辑器诱导的基因组切割后的同源定向修复机制来实现。将基因组编辑器引入受精卵并在胚胎中进行编辑具有发育成活体动物不受影响以及与当代基于胚胎的改良方法相一致的优势。在我们的研究中,我们研究了引入已知来自黑素小体前体蛋白17()和催乳素受体()基因的序列变异并产生非嵌合、编辑后的胚胎的潜力,这些胚胎完全转化为精确基因型。将gRNA/Cas9编辑器注射到牛受精卵中以在基因中引入一个3 bp的缺失变异,产生了高达11%的完全转化胚胎。使用TALEN时转化率提高到了高达48%,但仅当通过质粒递送时才如此。在几种已知的序列变异、不同的修复模板设计以及作为DNA、RNA或核糖核蛋白递送的背景下测试三种gRNA/Cas9编辑器,实现了高达8%的完全转化率。此外,我们开发了一种基于活检的非嵌合胚胎筛选策略,该策略有可能专门产生具有预期精确编辑的非嵌合动物。